KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Accumulated Expenses (2016 - 2025)

Evolent Health (EVH) has 11 years of Accumulated Expenses data on record, last reported at $55.4 million in Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 75.18% year-over-year to $55.4 million; the TTM value through Sep 2025 reached $55.4 million, up 75.18%, while the annual FY2024 figure was $33.7 million, 40.2% down from the prior year.
  • Accumulated Expenses reached $55.4 million in Q3 2025 per EVH's latest filing, up from $38.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $165.1 million in Q1 2024 and bottomed at $19.4 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $68.5 million, with a median of $55.4 million recorded in 2025.
  • The widest YoY moves for Accumulated Expenses: up 75.18% in 2025, down 54.87% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $107.2 million in 2021, then grew by 3.69% to $111.2 million in 2022, then plummeted by 49.29% to $56.4 million in 2023, then plummeted by 40.2% to $33.7 million in 2024, then soared by 64.24% to $55.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $55.4 million in Q3 2025, $38.3 million in Q2 2025, and $99.5 million in Q1 2025.